1. Feasibility and Outcome of Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant High-Dose Cyclophosphamide for Children and Adolescents with Hematologic Malignancies: An AIEOP-GITMO Retrospective Multicenter Study 
Massimo Berger, Edoardo Lanino, Simone Cesaro, Marco Zecca, Elena Vassallo, Maura Faraci, Massimiliano De Bortoli, Veronica Barat, Arcangelo Prete, Franca Fagioli 
Biology of Blood and Marrow Transplantation 
Volume 22, Issue 5, Pages (May 2016)
DOI: /j.bbmt
Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Immunologic reconstitution after PTCy haplo-HSCT. (A) CD3+CD4+/μL. (B) CD3+CD8+/μL. (C) CD19+/μL. (D) CD3-CD56+/μL.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2 Rates of 1-year OS and PFS for all patients given PTCy.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
Rates of 1-year RI for patients given PTCy haplo-HSCT. N indicates number of patients; E, events.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions